Author:
Sarkar Rashmi,Lakhani Ridhima
Abstract
BACKGROUND
Melasma is a common chronic, relapsing pigmentary disorder that causes psychological impact. Chemical peels are a well-known therapeutic modality used for accelerating the treatment of melasma.
OBJECTIVE
To review the published evidence on the efficacy and safety of chemical peels in the treatment of melasma.
METHODS
A systematic review was done. A meta-analysis could not be done due to the heterogeneity of data.
RESULT
The authors conducted a PubMed search and included prospective case series of more than 10 cases and randomized controlled trials (RCTs) that have studied the safety and/or efficacy of chemical peel in melasma. Out of 24 studies, 9 were clinical/comparative trials and 15 were RCTs. The total sample size was 1,075. The duration of the study varied from 8 to 36 weeks. Only 8 studies were split face. All studies used self-assessment, physician global assessment, and Melasma Area and Severity Index (MASI) for quantifying the results. Glycolic acid was found to be the most safe and effective in melasma.
CONCLUSION
Chemical peels were found to be safe and effective in the management of melasma.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference37 articles.
1. Melasma: a comprehensive update: part I;Sheth;J Am Acad Dermatol,2011
2. Melasma in orientals;Sivayathorn;Clin Drug Invest,1995
3. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex;Werlinger;Arch Dermatol,2007
4. Melasma treatment: an evidence-based review;McKesey;Am J Clin Dermatol,2020
5. An advanced, physician-strength retinol peel improves signs of aging and acne across a range of skin types including melasma and skin of color;Sadick;J Drugs Dermatol,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献